Insights from 2023 ESMO Annual Meeting
ESMO 2023 Insights: "ARASENS Trial - PSA Outcomes With Darolutamide, ADT, and Docetaxel in Patients With High- and Low-Volume mHSPC"
By
Insights from 2023 ESMO Annual Meeting
FEATURING
Fred Saad
By
Insights from 2023 ESMO Annual Meeting
FEATURING
Fred Saad
Login to view comments.
Click here to Login
Genitourinary